AusPAR: Selexipag

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

17 November 2016
AusPAR Details
AusPAR
AusPAR: Selexipag (pdf, 2 MB)
AusPAR: Selexipag (docx, 2 MB)
Attachment: Product Information: Selexipag (pdf, 1019 KB)
Attachment: Product Information: Selexipag (docx, 841 KB)
Attachment: Extract from Clinical Evaluation Report: Product Information: Selexipag (pdf, 5 MB)
Attachment: Extract from Clinical Evaluation Report: Product Information: Selexipag (docx, 10 MB)
Active Ingredient
Selexipag
Product Name
Uptravi
Sponsor
Actelion Pharmaceuticals Pty Ltd
Submission Number
PM-2014-04586-1-3
Submission Type
New chemical entity
Decision
Approved
AusPAR Date
8 November 2016
Publication Date

17 November 2016
Category: 
Prescription medicines
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/732811